Literature DB >> 16428892

Growth and production of the dengue virus in C6/36 cells and identification of a laminin-binding protein as a candidate serotype 3 and 4 receptor protein.

Prirayapak Sakoonwatanyoo1, Verawan Boonsanay, Duncan R Smith.   

Abstract

OBJECTIVES: Although dengue is one of the most common mosquito-borne viral diseases, few studies have investigated the relationship between the dengue virus and mosquito cells, and this study sought to describe the binding and propagation of the dengue viruses in C6/36 cells.
METHODS: The internalization and production of the dengue virus was assayed by standard plaque assay methodologies, while dengue virus receptor proteins were examined by a virus overlay protein-binding assay and candidate gene analysis coupled with virus inhibition studies.
RESULTS: All four serotypes were internalized linearly, and de novo virus production occurred 14-19 h postinfection. Virus overlay protein-binding assay identified a band of 50 kDa for dengue serotypes 2, 3 and 4 which comigrated with a protein that reacts with antibodies directed against the human 37/67-kDa high-affinity laminin receptor. Both antibodies directed against the human 37/67-kDa high-affinity laminin receptor protein and soluble laminin inhibited the binding and internalization of serotypes 3 and 4, but not serotypes 1 and 2.
CONCLUSIONS: The results suggest that multiple receptors may be used by the dengue virus to enter into insect cells, and that one of these proteins may be a laminin-binding protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16428892     DOI: 10.1159/000089377

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  27 in total

Review 1.  Molecular mechanisms involved in the early steps of flavivirus cell entry.

Authors:  Bärbel Kaufmann; Michael G Rossmann
Journal:  Microbes Infect       Date:  2010-12-10       Impact factor: 2.700

Review 2.  Protein Interactions during the Flavivirus and Hepacivirus Life Cycle.

Authors:  Gisa Gerold; Janina Bruening; Bettina Weigel; Thomas Pietschmann
Journal:  Mol Cell Proteomics       Date:  2017-01-11       Impact factor: 5.911

3.  The laminin receptor is a cellular attachment receptor for classical Swine Fever virus.

Authors:  Jianing Chen; Wen-Rui He; Liang Shen; Hong Dong; Jiahui Yu; Xiao Wang; Shaoxiong Yu; Yongfeng Li; Su Li; Yuzi Luo; Yuan Sun; Hua-Ji Qiu
Journal:  J Virol       Date:  2015-02-18       Impact factor: 5.103

4.  Investigation of the Cry4B-prohibitin interaction in Aedes aegypti cells.

Authors:  Atichat Kuadkitkan; Duncan R Smith; Colin Berry
Journal:  Curr Microbiol       Date:  2012-07-06       Impact factor: 2.188

5.  A gradient-free method for the purification of infective dengue virus for protein-level investigations.

Authors:  Stephanie M Jensen; Celina T Nguyen; John C Jewett
Journal:  J Virol Methods       Date:  2016-06-02       Impact factor: 2.014

6.  Use of a tandem affinity purification assay to detect interactions between West Nile and dengue viral proteins and proteins of the mosquito vector.

Authors:  Tonya M Colpitts; Jonathan Cox; Annie Nguyen; Fabiana Feitosa; Manoj N Krishnan; Erol Fikrig
Journal:  Virology       Date:  2011-06-23       Impact factor: 3.616

7.  Dengue virus entry as target for antiviral therapy.

Authors:  Marijke M F Alen; Dominique Schols
Journal:  J Trop Med       Date:  2012-03-04

8.  Transcriptional Response of Wolbachia to Dengue Virus Infection in Cells of the Mosquito Aedes aegypti.

Authors:  Michael Leitner; Cameron Bishop; Sassan Asgari
Journal:  mSphere       Date:  2021-06-30       Impact factor: 4.389

Review 9.  Recent advances in DENV receptors.

Authors:  Shuyu Fang; Yanhua Wu; Na Wu; Jing Zhang; Jing An
Journal:  ScientificWorldJournal       Date:  2013-04-23

Review 10.  The battle between infection and host immune responses of dengue virus and its implication in dengue disease pathogenesis.

Authors:  Peifang Sun; Tadeusz J Kochel
Journal:  ScientificWorldJournal       Date:  2013-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.